{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T14:04:52Z","timestamp":1792159492825,"version":"4.4.0"},"reference-count":167,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["mgmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.ymgme.2018.01.003","type":"journal-article","created":{"date-parts":[[2018,1,31]],"date-time":"2018-01-31T04:31:09Z","timestamp":1517373069000},"page":"4-17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":81,"title":["Clinical presentation and diagnosis of mucopolysaccharidoses"],"prefix":"10.1016","volume":"125","author":[{"given":"Molly","family":"Stapleton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nivethitha","family":"Arunkumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9330-0154","authenticated-orcid":false,"given":"Francyne","family":"Kubaski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"Mason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orii","family":"Tadao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunji","family":"Tomatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ymgme.2018.01.003_bb0005","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s10545-005-0112-z","article-title":"Cumulative incidence rates of the mucopolysaccharidoses in Germany","volume":"28","author":"Baehner","year":"2005","journal-title":"J. Inherit. Metab. Dis."},{"issue":"3","key":"10.1016\/j.ymgme.2018.01.003_bb0010","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/1479-7364-5-3-156","article-title":"Lysosomal storage disorders: molecular basis and laboratory testing","volume":"5","author":"Filocamo","year":"2011","journal-title":"Human Genom."},{"issue":"3","key":"10.1016\/j.ymgme.2018.01.003_bb0015","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ymgme.2017.05.016","article-title":"Epidemiology of mucopolysaccharidoses","volume":"121","author":"Khan","year":"2017","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.ymgme.2018.01.003_bb0020","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1146\/annurev.bi.53.070184.004215","article-title":"Cell-surface glycosaminoglycans","volume":"53","author":"H\u00f6\u00f6k","year":"1984","journal-title":"Annu. Rev. Biochem."},{"issue":"3","key":"10.1016\/j.ymgme.2018.01.003_bb0025","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1046\/j.1469-7580.2001.19930241.x","article-title":"Role of uppermost superficial surface layer of articular cartilage in the lubrication mechanism of joints","volume":"199","author":"Kumar","year":"2001","journal-title":"J. Anatom."},{"issue":"3","key":"10.1016\/j.ymgme.2018.01.003_bb0030","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.biomaterials.2009.09.063","article-title":"The effect of mean pore size on cell attachment, proliferation and migration in collagen\u2013glycosaminoglycan scaffolds for bone tissue engineering","volume":"31","author":"Murphy","year":"2010","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.ymgme.2018.01.003_bb0035","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/10409230091169195","article-title":"Structural and functional comparison of polysaccharide-degrading enzymes","volume":"35","author":"Jedrzejas","year":"2000","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"issue":"3","key":"10.1016\/j.ymgme.2018.01.003_bb0040","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1651-2227.1995.tb13640.x","article-title":"The presenting features of Mucopolysaccharidosis type II (hurler syndrome)","volume":"84","author":"Cleary","year":"1995","journal-title":"Acta Paediatr."},{"issue":"5","key":"10.1016\/j.ymgme.2018.01.003_bb0045","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/j.jpeds.2004.01.052","article-title":"The Mucopolysaccharidosis: a heterogeneous group of disorders with variable pediatric presentations","volume":"144","author":"Muenzer","year":"2004","journal-title":"J. Pediatr."},{"issue":"6","key":"10.1016\/j.ymgme.2018.01.003_bb0050","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/BF00711508","article-title":"A fluorimetric enzyme assay for the diagnosis of Sanfilippo disease type D (MPS IIID)","volume":"16","author":"He","year":"1993","journal-title":"J. Inherit. Metab. Dis."},{"issue":"3","key":"10.1016\/j.ymgme.2018.01.003_bb0055","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/BF01799255","article-title":"A fluorimetric enzyme assay for the diagnosis of Sanfilippo disease type A (MPS IIIA)","volume":"19","author":"Karpova","year":"1996","journal-title":"J. Inherit. Metab. Dis."},{"issue":"1","key":"10.1016\/j.ymgme.2018.01.003_bb0060","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ymgme.2014.07.013","article-title":"The laboratory diagnosis of mucopolysaccharidosis III (Sanfilippo syndrome): a changing landscape","volume":"113","author":"Bodamer","year":"2014","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2018.01.003_bb0065","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.ymgmr.2014.10.004","article-title":"Development of a fluorometric microtiter plate based enzyme assay for MPS IVA (Morquio type A) using dried blood spots","volume":"1","author":"Ullal","year":"2014","journal-title":"Molecular Genetics and Metabolism Reports"},{"issue":"5","key":"10.1016\/j.ymgme.2018.01.003_bb0070","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/apa.12169","article-title":"Mucopolysaccharidosis type III (Sanfilippo syndrome) and misdiagnosis of idiopathic developmental delay, attention deficit\/hyperactivity disorder or autism spectrum disorder","volume":"102","author":"Wijburg","year":"2013","journal-title":"Acta Paediatr."},{"issue":"2","key":"10.1016\/j.ymgme.2018.01.003_bb0075","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1542\/peds.2006-2184","article-title":"Management guidelines for mucopolysaccharidosis VI","volume":"120","author":"Giugliani","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2018.01.003_bb0080","series-title":"Health Care for People with Intellectual and Developmental Disabilities across the Lifespan","first-page":"641","article-title":"The Mucopolysaccharidoses","author":"Conway","year":"2016"},{"issue":"6","key":"10.1016\/j.ymgme.2018.01.003_bb0085","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s00431-011-1644-x","article-title":"Diagnosis and treatment trends in mucopolysaccharidosis I: findings from the MPS I registry","volume":"171","author":"D'Aco","year":"2012","journal-title":"Eur. J. Pediatr."},{"issue":"2","key":"10.1016\/j.ymgme.2018.01.003_bb0090","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ymgme.2013.11.015","article-title":"Early initiation of enzyme replacement therapy for the mucopolysaccharidoses","volume":"111","author":"Muenzer","year":"2014","journal-title":"Mol. Genet. Metab."},{"issue":"2","key":"10.1016\/j.ymgme.2018.01.003_bb0095","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1016\/j.ymgme.2014.12.208","article-title":"Early treatment with laronidase improves clinical outcomes in patients with attenuated MPS I: analysis of eight sibling pairs","volume":"114","author":"Pleat","year":"2015","journal-title":"Mol. Genet. Metab."},{"issue":"2","key":"10.1016\/j.ymgme.2018.01.003_bb0100","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ymgme.2014.12.001","article-title":"Therapies for the bone in mucopolysaccharidoses","volume":"114","author":"Tomatsu","year":"2015","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.ymgme.2018.01.003_bb0105","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ymgme.2016.09.005","article-title":"Glycosaminoglycans detection methods: applications of mass spectrometry","volume":"120","author":"Kubaski","year":"2017","journal-title":"Mol. Genet. Metab."},{"issue":"2","key":"10.1016\/j.ymgme.2018.01.003_bb0110","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ymgme.2014.11.002","article-title":"Activities of daily living in patients with hunter syndrome: impact of enzyme replacement therapy and hematopoietic stem cell transplantation","volume":"114","author":"Tanjuakio","year":"2015","journal-title":"Mol. Genet. Metab."},{"issue":"2","key":"10.1016\/j.ymgme.2018.01.003_bb0115","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10545-006-0265-4","article-title":"Direct multiplex assay of enzymes in dried blood spots by tandem mass spectrometry for the newborn screening of lysosomal storage disorders","volume":"29","author":"Gelb","year":"2006","journal-title":"J. Inherit. Metab. Dis."},{"issue":"12","key":"10.1016\/j.ymgme.2018.01.003_bb0120","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1373\/clinchem.2008.115410","article-title":"Tandem mass spectrometry for the direct assay of lysosomal enzymes in dried blood spots: application to screening newborns for mucopolysaccharidosis I","volume":"54","author":"Blanchard","year":"2008","journal-title":"Clin. Chem."},{"issue":"2","key":"10.1016\/j.ymgme.2018.01.003_bb0125","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2007-1350","article-title":"Recognition and diagnosis of mucopolysaccharidosis II (hunter syndrome)","volume":"121","author":"Martin","year":"2008","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.ymgme.2018.01.003_bb0130","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00431-007-0635-4","article-title":"Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy","volume":"167","author":"Wraith","year":"2008","journal-title":"Eur. J. Pediatr."},{"issue":"2","key":"10.1016\/j.ymgme.2018.01.003_bb0135","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/humu.1380010204","article-title":"A common mutation for mucopolysaccharidosis type I associated with a severe Hurler syndrome phenotype","volume":"1","author":"Scott","year":"1992","journal-title":"Hum. Mutat."},{"issue":"1","key":"10.1016\/j.ymgme.2018.01.003_bb0140","doi-asserted-by":"crossref","DOI":"10.1186\/1750-1172-3-24","article-title":"The prevalence of and survival in Mucopolysaccharidosis I: hurler, hurler-Scheie and Scheie syndromes in the UK","volume":"3","author":"Moore","year":"2008","journal-title":"Orphanet journal of rare diseases"},{"issue":"1","key":"10.1016\/j.ymgme.2018.01.003_bb0145","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/01.bor.0000147283.40529.13","article-title":"Musculoskeletal complications associated with lysosomal storage disorders: Gaucher disease and Hurler-Scheie syndrome (mucopolysaccharidosis type I)","volume":"17","author":"Pastores","year":"2005","journal-title":"Curr. Opin. Rheumatol."},{"issue":"5","key":"10.1016\/j.ymgme.2018.01.003_bb0150","first-page":"237","article-title":"Mucopolysaccharidosis type V.(Scheie syndrome). A postmortem study by multidisciplinary techniques with emphasis on the brain","volume":"100","author":"Dekaban","year":"1976","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.ymgme.2018.01.003_bb0155","first-page":"196","article-title":"Pediatric rheumatology attenuated type I mucopolysaccharidosis in the differential diagnosis of juvenile idiopathic arthritis: a series of 13 patients with Scheie syndrome","volume":"24","author":"Cimaz","year":"2006","journal-title":"Clin. Exp. Rheumatol."},{"issue":"4","key":"10.1016\/j.ymgme.2018.01.003_bb0160","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s10545-010-9113-7","article-title":"Childhood onset of Scheie syndrome, the attenuated form of mucopolysaccharidosis I","volume":"33","author":"Thomas","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"issue":"5","key":"10.1016\/j.ymgme.2018.01.003_bb0165","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/BF02396619","article-title":"Radiological findings in patients with mucopolysaccharidosis IH\/S (Hurler-Scheie syndrome)","volume":"17","author":"Schmidt","year":"1987","journal-title":"Pediatr. Radiol."},{"issue":"269","key":"10.1016\/j.ymgme.2018.01.003_bb0170","first-page":"305","article-title":"Hurler syndrome with special reference to histologic abnormalities of the growth plate","author":"Silveri","year":"1991","journal-title":"Clin. Orthop. Relat. Res."},{"issue":"3","key":"10.1016\/j.ymgme.2018.01.003_bb0175","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s12519-014-0517-6","article-title":"Growth patterns in children with mucopolysaccharidosis I and II","volume":"11","author":"R\u00f3\u017cd\u017cy\u0144ska-\u015awi\u0105tkowska","year":"2015","journal-title":"World J. Pediatr."},{"issue":"4","key":"10.1016\/j.ymgme.2018.01.003_bb0180","first-page":"286","article-title":"Can mucopolysaccharidosis type I disease severity be predicted based on a patient's genotype? A comprehensive review of the literature","volume":"5","author":"Terlato","year":"2003","journal-title":"Gen. Med."},{"key":"10.1016\/j.ymgme.2018.01.003_bb0185","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1002\/humu.23301","article-title":"IDUA mutational profile and genotype-phenotype relationships in UK patients with Mucopolysaccharidosis I","author":"Ghosh","year":"2017","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2018.01.003_bb0190","first-page":"104","article-title":"A rare disease in two brothers","volume":"10","author":"Hunter","year":"1917","journal-title":"Proc. R. Soc. Med."},{"issue":"7","key":"10.1016\/j.ymgme.2018.01.003_bb0195","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1073\/pnas.70.7.2134","article-title":"The defect in the hunter syndrome: deficiency of sulfoiduronate sulfatase","volume":"70","author":"Bach","year":"1973","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.ymgme.2018.01.003_bb0200","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/1750-1172-8-101","article-title":"The impact of Hunter syndrome (mucopolysaccharidosis type II) on health-related quality of life","volume":"8","author":"Raluy-Callado","year":"2013","journal-title":"Orphanet journal of rare diseases"},{"key":"10.1016\/j.ymgme.2018.01.003_bb0240","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ymgmr.2013.10.001","article-title":"Growth charts for patients with Hunter syndrome","volume":"1","author":"Patel","year":"2014","journal-title":"Molecular Genetics and Metabolism Reports"},{"issue":"4","key":"10.1016\/j.ymgme.2018.01.003_bb0245","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1365-2141.2004.05293.x","article-title":"Lysosomal storage disorders","volume":"128","author":"Vellodi","year":"2005","journal-title":"Br. J. Haematol."},{"issue":"4","key":"10.1016\/j.ymgme.2018.01.003_bb0250","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/21678707.2017.1296761","article-title":"Presentation and treatments for Mucopolysaccharidosis Type II (MPS II; Hunter Syndrome)","volume":"5","author":"Stapleton","year":"2017","journal-title":"Expert Opin. Orphan Drugs"},{"issue":"2","key":"10.1016\/j.ymgme.2018.01.003_bb0255","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s10545-011-9378-5","article-title":"Hearing loss in patients with mucopolysaccharidosis II: data from HOS\u2013the Hunter Outcome Survey","volume":"35","author":"Keilmann","year":"2012","journal-title":"J. Inherit. Metab. Dis."},{"issue":"2","key":"10.1016\/j.ymgme.2018.01.003_bb0260","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1399-0004.1981.tb01821.x","article-title":"Genetic heterogeneity and clinical variability in the Sanfilippo syndrome (types A, B, and C)","volume":"20","author":"Kamp","year":"1981","journal-title":"Clin. Genet."},{"issue":"7","key":"10.1016\/j.ymgme.2018.01.003_bb0265","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1073\/pnas.69.7.1720","article-title":"Sanfilippo syndrome: profound deficiency of alpha-acetylglucosaminidase activity in organs and skin fibroblasts from type-B patients","volume":"69","author":"O'brien","year":"1972","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"2","key":"10.1016\/j.ymgme.2018.01.003_bb0270","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s10545-008-0838-5","article-title":"Sanfilippo syndrome: a mini-review","volume":"31","author":"Valstar","year":"2008","journal-title":"J. Inherit. Metab. Dis."},{"issue":"6","key":"10.1016\/j.ymgme.2018.01.003_bb0275","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1002\/ana.22092","article-title":"Mucopolysaccharidosis type IIIA: clinical spectrum and genotype-phenotype correlations","volume":"68","author":"Valstar","year":"2010","journal-title":"Ann. Neurol."},{"issue":"6","key":"10.1016\/j.ymgme.2018.01.003_bb0280","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/j.1399-0004.1979.tb00832.x","article-title":"Sanfilippo B syndrome (MPS III B): mild and severe forms within the same sibship","volume":"15","author":"Andria","year":"1979","journal-title":"Clin. Genet."},{"issue":"4","key":"10.1016\/j.ymgme.2018.01.003_bb0285","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/humu.1189","article-title":"Molecular genetics of mucopolysaccharidosis type IIIA and IIIB: diagnostic, clinical, and biological implications","volume":"18","author":"Yogalingam","year":"2001","journal-title":"Hum. Mutat."},{"issue":"2","key":"10.1016\/j.ymgme.2018.01.003_bb0290","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s10545-012-9558-y","article-title":"Parental social support, coping strategies, resilience factors, stress, anxiety and depression levels in parents of children with MPS III (Sanfilippo syndrome) or children with intellectual disabilities (ID)","volume":"36","author":"Grant","year":"2013","journal-title":"J. Inherit. Metab. Dis."},{"issue":"2","key":"10.1016\/j.ymgme.2018.01.003_bb0295","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ymgme.2007.09.011","article-title":"Clinical and genetic spectrum of Sanfilippo type C (MPS IIIC) disease in the Netherlands","volume":"93","author":"Ruijter","year":"2008","journal-title":"Mol. Genet. Metab."},{"issue":"3","key":"10.1016\/j.ymgme.2018.01.003_bb0300","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1136\/adc.69.3.403","article-title":"Management of mucopolysaccharidosis type III","volume":"69","author":"Cleary","year":"1993","journal-title":"Arch. Dis. Child."},{"issue":"5","key":"10.1016\/j.ymgme.2018.01.003_bb0305","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.jpeds.2014.01.007","article-title":"Acquired autistic behaviors in children with mucopolysaccharidosis type IIIA","volume":"164","author":"Rumsey","year":"2014","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2018.01.003_bb0310","article-title":"Morquio-like syndrome (MPS IV B) associated with deficiency of a \u03b2-galactosidase","author":"Trojak","year":"1980","journal-title":"Johns Hopkins Med. J."},{"key":"10.1016\/j.ymgme.2018.01.003_bb0315","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/ajmg.1320010205","article-title":"Mild Morquio syndrome (MPS-IV B) with keratansulfaturia but normal 6-sulfatase activity","volume":"1","author":"Arbisser","year":"1977","journal-title":"Am. J. Med. Genet."},{"issue":"4","key":"10.1016\/j.ymgme.2018.01.003_bb0320","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/BF00281685","article-title":"Morquio syndrome: clinical findings in 11 patients with MPS IVA and 2 patients with MPS IVB","volume":"57","author":"Holzgreve","year":"1981","journal-title":"Hum. Genet."},{"issue":"5","key":"10.1016\/j.ymgme.2018.01.003_bb0325","first-page":"1091","article-title":"Human beta-galactosidase gene mutations in morquio B disease","volume":"49","author":"Oshima","year":"1991","journal-title":"Am. J. Hum. Genet."},{"issue":"4","key":"10.1016\/j.ymgme.2018.01.003_bb0330","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jocd.2016.08.051","article-title":"Novel findings: bone mineral density in mucopolysaccharidosis IVB","volume":"19","author":"Kecskemethy","year":"2016","journal-title":"J. Clin. Densitom."},{"issue":"1","key":"10.1016\/j.ymgme.2018.01.003_bb0335","doi-asserted-by":"crossref","first-page":"S132","DOI":"10.1016\/j.ymgme.2016.11.347","article-title":"Etiology of mucopolysaccharidoses","volume":"120","author":"Tomatsu","year":"2017","journal-title":"Mol. Genet. Metab."},{"issue":"2","key":"10.1016\/j.ymgme.2018.01.003_bb0340","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s10545-007-0529-7","article-title":"International Morquio a registry: clinical manifestation and natural course of Morquio a disease","volume":"30","author":"Monta\u00f1o","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"issue":"6","key":"10.1016\/j.ymgme.2018.01.003_bb0345","doi-asserted-by":"crossref","first-page":"931","DOI":"10.2174\/138920111795542615","article-title":"Mucopolysaccharidosis type IVA (Morquio a disease): clinical review and current treatment: a special review","volume":"12","author":"Tomatsu","year":"2011","journal-title":"Curr. Pharm. Biotechnol."},{"issue":"1","key":"10.1016\/j.ymgme.2018.01.003_bb0350","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ymgme.2013.04.002","article-title":"Review of clinical presentation and diagnosis of mucopolysaccharidosis IVA","volume":"110","author":"Hendriksz","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2018.01.003_bb0355","doi-asserted-by":"crossref","unstructured":"Tomatsu, Shunji, et al. \"Obstructive airway in Morquio a syndrome, the past, the present and the future.\" Mol. Genet. Metab. 117.2 (2016): 150\u2013156.","DOI":"10.1016\/j.ymgme.2015.09.007"},{"issue":"9","key":"10.1016\/j.ymgme.2018.01.003_bb0360","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/j.1460-9592.2012.03904.x","article-title":"Anesthetic care and perioperative complications of children with Morquio syndrome","volume":"22","author":"Theroux","year":"2012","journal-title":"Pediatr. Anesth."},{"issue":"1","key":"10.1016\/j.ymgme.2018.01.003_bb0365","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ymgme.2013.01.021","article-title":"The Morquio A clinical assessment program: baseline results illustrating progressive, multisystemic clinical impairments in Morquio a subjects","volume":"109","author":"Harmatz","year":"2013","journal-title":"Mol. Genet. Metab."},{"issue":"5","key":"10.1016\/j.ymgme.2018.01.003_bb0370","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/j.1651-2227.2009.01134.x","article-title":"Sacral dimple: incidental findings from newborn evaluation (case presentation)","volume":"98","author":"Ohashi","year":"2009","journal-title":"Acta Paediatr."},{"issue":"4","key":"10.1016\/j.ymgme.2018.01.003_bb0375","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1590\/S1415-47572010005000093","article-title":"Mucopolysaccharidosis I, II, and VI: brief review and guidelines for treatment","volume":"33","author":"Giugliani","year":"2010","journal-title":"Genet. Mol. Biol."},{"issue":"1","key":"10.1016\/j.ymgme.2018.01.003_bb0380","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1023\/A:1005447232027","article-title":"Bone marrow transplantation for Maroteaux\u2013Lamy syndrome (MPS VI): long-term follow-up","volume":"22","author":"Herskhovitz","year":"1999","journal-title":"J. Inherit. Metab. Dis."},{"issue":"10","key":"10.1016\/j.ymgme.2018.01.003_bb0385","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/BF02830840","article-title":"Maroteaux-Lamy syndrome","volume":"71","author":"Lakhotia","year":"2004","journal-title":"Indian J. Pediatr."},{"issue":"3","key":"10.1016\/j.ymgme.2018.01.003_bb0390","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ymgme.2005.02.008","article-title":"An index case for the attenuated end of the mucopolysaccharidosis type VI clinical spectrum","volume":"85","author":"Brooks","year":"2005","journal-title":"Mol. Genet. Metab."},{"issue":"5","key":"10.1016\/j.ymgme.2018.01.003_bb0395","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1203\/01.PDR.0000156510.96253.5A","article-title":"Joint and bone disease in mucopolysaccharidoses VI and VII: identification of new therapeutic targets and biomarkers using animal models","volume":"57","author":"Simonaro","year":"2005","journal-title":"Pediatr. Res."},{"issue":"6","key":"10.1016\/j.ymgme.2018.01.003_bb0400","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1001\/archpedi.1973.02110190597003","article-title":"Mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome): I. Sulfatase B deficiency in tissues","volume":"126","author":"Stumpf","year":"1973","journal-title":"Am. J. Dis. Child."},{"issue":"1","key":"10.1016\/j.ymgme.2018.01.003_bb0405","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ymgme.2014.10.010","article-title":"Diagnostic evaluation, monitoring, and perioperative management of spinal cord compression in patients with Morquio syndrome","volume":"114","author":"Charrow","year":"2015","journal-title":"Mol. Genet. Metab."},{"issue":"6","key":"10.1016\/j.ymgme.2018.01.003_bb0410","first-page":"1553","article-title":"Mucopolysaccharidosis type VII (Sly syndrome). Beta-glucuronidase-deficient mucopolysaccharidosis in the dog","volume":"138","author":"Haskins","year":"1991","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ymgme.2018.01.003_bb0415","first-page":"59","article-title":"Mortality in patients with Morquio syndrome A","volume":"15","author":"Lavery","year":"2014","journal-title":"JIMD Reports"},{"issue":"4","key":"10.1016\/j.ymgme.2018.01.003_bb0420","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/humu.20828","article-title":"Mutations and polymorphisms in GUSB gene in mucopolysaccharidosis VII (Sly Syndrome)","volume":"30","author":"Tomatsu","year":"2009","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2018.01.003_bb0425","doi-asserted-by":"crossref","DOI":"10.1136\/jmedgenet-2015-103322","article-title":"Clinical course of sly syndrome (mucopolysaccharidosis type VII)","author":"Monta\u00f1o","year":"2016","journal-title":"J. Med. Genet."},{"issue":"3","key":"10.1016\/j.ymgme.2018.01.003_bb0430","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1399-0004.2004.00277.x","article-title":"Clinical and biochemical study of 28 patients with mucopolysaccharidosis type VI","volume":"66","author":"Azevedo","year":"2004","journal-title":"Clin. Genet."},{"issue":"1","key":"10.1016\/j.ymgme.2018.01.003_bb0435","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1750-1172-7-86","article-title":"Lysosomal storage disorder in non-immunological hydrops fetalis (NIHF)-more common than assumed? Report of four cases with transient NIHF and a review of the literature","volume":"7","author":"Whybra","year":"2012","journal-title":"Orphanet journal of rare diseases"},{"issue":"1","key":"10.1016\/j.ymgme.2018.01.003_bb0440","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.gene.2015.09.062","article-title":"Large scale analysis of the mutational landscape in \u03b2-glucuronidase: a major player of mucopolysaccharidosis type VII","volume":"576","author":"Khan","year":"2016","journal-title":"Gene"},{"issue":"5","key":"10.1016\/j.ymgme.2018.01.003_bb0445","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.carpath.2015.06.001","article-title":"Cardiovascular pathologies in mucopolysaccharidosis type VII (sly syndrome)","volume":"24","author":"Gniadek","year":"2015","journal-title":"Cardiovasc. Pathol."},{"issue":"14","key":"10.1016\/j.ymgme.2018.01.003_bb0450","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1056\/NEJM199610033351405","article-title":"Clinical and biochemical manifestations of hyaluronidase deficiency","volume":"335","author":"Natowicz","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2018.01.003_bb0455","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/8904_2015_467","article-title":"Screening Mucopolysaccharidosis type IX in patients with juvenile idiopathic arthritis","volume":"25","author":"Kiykim","year":"2015","journal-title":"JIMD Reports"},{"issue":"5","key":"10.1016\/j.ymgme.2018.01.003_bb0460","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s10545-011-9343-3","article-title":"A complete deficiency of Hyaluronoglucosaminidase 1 (HYAL1) presenting as familial juvenile idiopathic arthritis","volume":"34","author":"Imundo","year":"2011","journal-title":"J. Inherit. Metab. Dis."},{"issue":"13","key":"10.1016\/j.ymgme.2018.01.003_bb0465","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1093\/hmg\/ddn088","article-title":"A mouse model of human mucopolysaccharidosis IX exhibits osteoarthritis","volume":"17","author":"Martin","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2018.01.003_bb0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2017.05.005","article-title":"Cognitive and adaptive measurement endpoints for clinical trials in mucopolysaccharidoses types I, II, and III: a review of the literature","author":"Janzen","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2018.01.003_bb0475","series-title":"Kaufman Assessment Battery for Children, Second Edition (KABC-II)","author":"Kaufman","year":"2004"},{"issue":"9","key":"10.1016\/j.ymgme.2018.01.003_bb0480","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1212\/01.wnl.0000269782.80107.fe","article-title":"Brain MRI in mucopolysaccharidosis: effect of aging and correlation with biochemical findings","volume":"69","author":"Vedolin","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2018.01.003_bb0485","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ymgme.2014.12.299","article-title":"Cognitive, medical, and neuroimaging characteristics of attenuated mucopolysaccharidosis type II","volume":"114","author":"Yund","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2018.01.003_bb0490","series-title":"Academic Skills Problems: Direct Assessment and Intervention","author":"Shapiro","year":"2011"},{"key":"10.1016\/j.ymgme.2018.01.003_bb0495","series-title":"Wechsler Preschool and Primary Scale of Intelligence, 4th ed.(WPPSI-IV)","author":"Wechsler","year":"2012"},{"key":"10.1016\/j.ymgme.2018.01.003_bb0500","series-title":"Wechsler Abbreviated Scale of Intelligence\u2013Second Edition (WASI-II)","author":"Wechsler","year":"2011"},{"key":"10.1016\/j.ymgme.2018.01.003_bb0505","series-title":"Wechsler Adult Intelligence Scale\u2014Fourth edition","author":"Wechsler","year":"2008"},{"issue":"1","key":"10.1016\/j.ymgme.2018.01.003_bb0510","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ymgme.2007.01.011","article-title":"The MPS I registry: design, methodology, and early findings of a global disease registry for monitoring patients with Mucopolysaccharidosis Type I","volume":"91","author":"Pastores","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2018.01.003_bb0515","series-title":"The Hunter Syndrome-Functional Outcomes for Clinical Understanding Scale","author":"Wiklund","year":"2013"},{"key":"10.1016\/j.ymgme.2018.01.003_bb0520","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s11136-006-9134-8","article-title":"Reliability and validity of the Infant and Toddler Quality of Life Questionnaire (ITQOL) in a general population and respiratory disease sample","volume":"16","author":"Raat","year":"2007","journal-title":"Qual. Life Res."},{"key":"10.1016\/j.ymgme.2018.01.003_bb0525","author":"Landgraf"},{"issue":"9","key":"10.1016\/j.ymgme.2018.01.003_bb0530","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/gt.2017.29","article-title":"The importance of international collaboration for rare diseases research: a European perspective","volume":"24","author":"Julkowska","year":"2017","journal-title":"Gene Ther."},{"issue":"2","key":"10.1016\/j.ymgme.2018.01.003_bb0535","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ymgme.2016.04.005","article-title":"Activity of daily living for Morquio A syndrome","volume":"118","author":"Yasuda","year":"2016","journal-title":"Mol. Genet. Metab."},{"issue":"6","key":"10.1016\/j.ymgme.2018.01.003_bb0540","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1097\/01241398-199611000-00006","article-title":"Hip dysplasia in Hurler's syndrome: orthopaedic management after bone marrow transplantation","volume":"16","author":"Masterson","year":"1996","journal-title":"J. Pediatr. Orthop."},{"issue":"2","key":"10.1016\/j.ymgme.2018.01.003_bb0545","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ymgme.2014.03.004","article-title":"Molecular testing of 163 patients with Morquio A (Mucopolysaccharidosis IVA) identifies 39 novel GALNS mutations","volume":"112","author":"Morrone","year":"2014","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.ymgme.2018.01.003_bb0550","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/1750-1172-8-155","article-title":"Treatment of hip dysplasia in patients with mucopolysaccharidosis type I after hematopoietic stem cell transplantation: results of an international consensus procedure","volume":"8","author":"Langereis","year":"2013","journal-title":"Orphan. J. Rare Dis."},{"issue":"4","key":"10.1016\/j.ymgme.2018.01.003_bb0555","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2174\/157016411798220871","article-title":"Analysis of glycosaminoglycans using mass spectrometry","volume":"8","author":"Staples","year":"2011","journal-title":"Curr. Proteom."},{"issue":"3","key":"10.1016\/j.ymgme.2018.01.003_bb0560","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/ajmg.a.20515","article-title":"Correlation between cerebral MRI abnormalities and mental retardation in patients with mucopolysaccharidoses","volume":"125","author":"Gabrielli","year":"2004","journal-title":"Am. J. Med. Genet. A"},{"issue":"8","key":"10.1016\/j.ymgme.2018.01.003_bb0565","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1007\/s00234-004-1215-1","article-title":"Brain MRI findings in patients with mucopolysaccharidosis types I and II and mild clinical presentation","volume":"46","author":"Matheus","year":"2004","journal-title":"Neuroradiology"},{"issue":"10","key":"10.1016\/j.ymgme.2018.01.003_bb0570","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/j.bbmt.2017.06.020","article-title":"Hematopoietic stem cell transplantation for patients with mucopolysaccharidosis II","volume":"23","author":"Kubaski","year":"2017","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"1","key":"10.1016\/j.ymgme.2018.01.003_bb0575","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1750-1172-5-5","article-title":"Mucopolysaccharidosis vi","volume":"5","author":"Valayannopoulos","year":"2010","journal-title":"Orphanet journal of rare diseases"},{"issue":"1","key":"10.1016\/j.ymgme.2018.01.003_bb0580","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ymgme.2013.06.007","article-title":"Newborn screening and diagnosis of mucopolysaccharidoses","volume":"110","author":"Tomatsu","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2018.01.003_bb0585","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ymgme.2010.09.003","article-title":"Efficient analysis of urinary glycosaminoglycans by LC\u2013MS\/MS in mucopolysaccharidoses type I, II and VI","volume":"102","author":"Auray-Blais","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2018.01.003_bb0590","doi-asserted-by":"crossref","first-page":"179","DOI":"10.4155\/bio.15.239","article-title":"Evaluation of urinary keratan sulfate disaccharides in MPS IVA patients using UPLC-MS\/MS","volume":"8","author":"Auray-Blais","year":"2016","journal-title":"Bioanalysis"},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2018.01.003_bb0595","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0009-8981(93)90031-X","article-title":"Diagnosis of mucopolysaccharidoses in a clinically selected population by urinary glycosaminoglycan analysis: a study of 2,000 urinary samples","volume":"221","author":"Piraud","year":"1993","journal-title":"Clin. Chimica."},{"issue":"1","key":"10.1016\/j.ymgme.2018.01.003_bb0600","article-title":"Separation of sulfated urinary glycosaminoglycans by high-resolution electrophoresis for isotyping of mucopolysaccharidoses in Malaysia","volume":"32","author":"Azize","year":"2010","journal-title":"Malays. J. Pathol."},{"issue":"6","key":"10.1016\/j.ymgme.2018.01.003_bb0605","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/clinchem\/38.6.803","article-title":"Measuring urinary glycosaminoglycans in the presence of protein: an improved screening procedure for mucopolysaccharidoses based on dimethylmethylene blue","volume":"38","author":"De Jong","year":"1992","journal-title":"Clin. Chem."},{"issue":"4","key":"10.1016\/j.ymgme.2018.01.003_bb0610","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1074\/mcp.R112.026294","article-title":"Glycosaminoglycan glycomics using mass spectrometry","volume":"12","author":"Zaia","year":"2013","journal-title":"Mol. Cell. Proteomics"},{"issue":"3","key":"10.1016\/j.ymgme.2018.01.003_bb0615","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1177\/000456329403100309","article-title":"Mucopolysaccharidoses screening: dimethylmethylene blue versus alcian blue","volume":"31","author":"De Jong","year":"1994","journal-title":"Ann. Clin. Biochem."},{"issue":"1","key":"10.1016\/j.ymgme.2018.01.003_bb0620","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.cccn.2004.03.015","article-title":"Evaluation of reliability for urine mucopolysaccharidosis screening by dimethylmethylene blue and Berry spot tests","volume":"345","author":"Mabe","year":"2004","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ymgme.2018.01.003_bb0625","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1097\/01.PAT.0000461571.35900.1a","article-title":"Performance of the dimethylmethylene blue test for the diagnosis of mucopolysaccharidoses","volume":"47","author":"Carpenter","year":"2015","journal-title":"Pathology"},{"issue":"09","key":"10.1016\/j.ymgme.2018.01.003_bb0630","first-page":"4269","article-title":"Dimethylmethylene blue: a tool for MPS screening","volume":"4","author":"Pandey","year":"2015","journal-title":"Int. J. Bioassays"},{"key":"10.1016\/j.ymgme.2018.01.003_bb0635","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.cca.2016.11.015","article-title":"Screening for mucopolysaccharidoses in the Turkish population: analytical and clinical performance of an age-range specific, dye-based, urinary glycosaminoglycan assay","volume":"464","author":"El Moustafa","year":"2017","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ymgme.2018.01.003_bb0640","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1093\/clinchem\/35.3.374","article-title":"Diagnostic test for mucopolysaccharidosis: I. Direct method for quantifying excessive urinary glycosaminoglycan excretion","volume":"35","author":"Whitley","year":"1989","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ymgme.2018.01.003_bb0645","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1093\/clinchem\/35.7.1472","article-title":"Dimethylmethylene bluebased spectrophotometry of glycosaminoglycans in untreated urine: a rapid screening procedure for mucopolysaccharidoses","volume":"35","author":"de Jong","year":"1989","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ymgme.2018.01.003_bb0650","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1055\/s-0028-1115166","article-title":"Vorzuge der kombinierten Alcian blau PerjodsFure-Sehiff-Reaktion fur die gynh-kologiseheHistopathologie","volume":"81","author":"Runoe","year":"1956","journal-title":"Deutsche. Med. Wchnsehr"},{"key":"10.1016\/j.ymgme.2018.01.003_bb0655","article-title":"Urinary glycosaminoglycan electrophoresis with optimized keratin sulfate separation using peltier system for the screening of mucopolysaccharidoses","volume":"3","author":"Tanyalicn","year":"2015","journal-title":"J. Inborn Errors Metab. Screen."},{"key":"10.1016\/j.ymgme.2018.01.003_bb0660","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0003-2697(79)90061-7","article-title":"A simple spectrophotometric method for estimating glycosaminoglycan concentrations","volume":"99","author":"Gold","year":"1979","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ymgme.2018.01.003_bb0665","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1055\/s-0028-1095171","article-title":"Thin layer chromatography of urinary acid glycosaminoglycans as screening procedure for mucopolysaccharidoses","volume":"1","author":"Teller","year":"1969","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.ymgme.2018.01.003_bb0670","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.ymgme.2012.09.024","article-title":"Heparan sulfate and dermatan sulfate derived disaccharides are sensitive markers for newborn screening for mucopolysaccharidoses type I, II and III","volume":"107","author":"Ruijter","year":"2012","journal-title":"MGM"},{"key":"10.1016\/j.ymgme.2018.01.003_bb0675","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0021-9673(95)00265-0","article-title":"Separation of acidic carbohydrates by capillary electrophoresis","volume":"720","author":"Linhardt","year":"1996","journal-title":"J. Chromat. A"},{"key":"10.1016\/j.ymgme.2018.01.003_bb0680","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0009-8981(94)90026-4","article-title":"F.S. ELISA for the core protein of the cartilage large aggregating proteoglycan, aggrecan: comparsion with the concentrations of immunogenic keratan sulphate in synovial fluid, serum and urine","volume":"225","author":"M\u00f8ller","year":"1994","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ymgme.2018.01.003_bb0685","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1006\/cyto.1997.0246","article-title":"Characterization of human recombinant interleukin 2 binding to heparin and heparan sulfate using an ELISA approach","volume":"9","author":"Najjam","year":"1997","journal-title":"Cytokine"},{"issue":"4","key":"10.1016\/j.ymgme.2018.01.003_bb0690","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0006-2944(75)90064-2","article-title":"Lack of relationship between blood and urine levels of glycosaminoglycan's and lysosomal enzymes","volume":"12","author":"Erickson","year":"1975","journal-title":"Biochem. Med."},{"issue":"5","key":"10.1016\/j.ymgme.2018.01.003_bb0695","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/bmc.74","article-title":"Analytical method of chondroitin\/dermatan sulfates using high performance liquid chromatography\/turbo ionspray ionization mass spectrometry: application to analyses of the tumor tissue sections on glass slides","author":"Oguma","year":"2001","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.ymgme.2018.01.003_bb0700","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ab.2007.05.016","article-title":"Analytical method for the determination of disaccharides derived from keratan, heparan, and dermatan sulfates in human serum and plasma by high-performance liquid chromatography\/turbo ionspray ionization tandem mass spectrometry","volume":"368","author":"Oguma","year":"2007","journal-title":"Anal. Biochem."},{"issue":"5","key":"10.1016\/j.ymgme.2018.01.003_bb0705","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1007\/s00216-016-0076-x","article-title":"Multimodal detection of GM2 and GM3 lipid species in the brain of mucopolysaccharidosis type II mouse by serial imaging mass spectrometry and immunohistochemistry","volume":"409","author":"Dufresne","year":"2017","journal-title":"Anal. Bioanal. Chem."},{"issue":"2","key":"10.1016\/j.ymgme.2018.01.003_bb0710","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s10545-009-9036-3","article-title":"Dermatan sulfate and heparan sulfate as a biomarker for mucopolysaccharidosis I","volume":"33","author":"Tomatsu","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"issue":"5","key":"10.1016\/j.ymgme.2018.01.003_bb0715","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3109\/10409239509083490","article-title":"Enzymatic degradation of glycosaminogIycans","volume":"30","author":"Ernst","year":"1995","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"10.1016\/j.ymgme.2018.01.003_bb0720","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/rcm.6861","article-title":"A simple method for early age phenotype confirmation using toe tissue from a mouse model of MPS IIIA","volume":"28","author":"Trim","year":"2014","journal-title":"Rapid Commun. Mass Spectrom."},{"issue":"2","key":"10.1016\/j.ymgme.2018.01.003_bb0725","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nchembio.766","article-title":"Disease-specific non\u2013reducing end carbohydrate biomarkers for mucopolysaccharidoses","volume":"8","author":"Lawrence","year":"2012","journal-title":"Nat. Chem. Biol."},{"issue":"2","key":"10.1016\/j.ymgme.2018.01.003_bb0730","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1016\/j.ymgme.2012.11.192","article-title":"Analysis of non-reducing ends (NRE) of glycosaminoglycans for the diagnosis and monitoring of therapy in Mucopolysaccharidosis type I","volume":"108","author":"Pasquali","year":"2013","journal-title":"Mol. Genet. Metab."},{"issue":"11","key":"10.1016\/j.ymgme.2018.01.003_bb0735","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1373\/clinchem.2015.242560","article-title":"Tandem mass spectrometry has a larger analytical range than fluorescence assays of lysosomal enzymes: application to newborn screening and diagnosis of mucopolysaccharidoses types II, IVA, and VI","volume":"61","author":"Kumar","year":"2015","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ymgme.2018.01.003_bb0740","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1373\/clinchem.2010.161141","article-title":"Analysis of glycosaminoglycans in cerebrospinal fluid from patients with mucopolysaccharidoses by isotope-dilution ultra-performance liquid chromatography-tandem mass spectrometry","volume":"57","author":"Zhang","year":"2011","journal-title":"Clin. Chem."},{"issue":"1","key":"10.1016\/j.ymgme.2018.01.003_bb0745","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ymgme.2014.07.008","article-title":"Novel heparan sulfate assay by using automated high-throughput mass spectrometry: application to monitoring and screening for mucopolysaccharidoses","volume":"113","author":"Shimada","year":"2014","journal-title":"Mol. Genet. Metab."},{"issue":"suppl_5","key":"10.1016\/j.ymgme.2018.01.003_bb0750","doi-asserted-by":"crossref","first-page":"v4","DOI":"10.1093\/rheumatology\/ker394","article-title":"Overview of the mucopolysaccharidoses","volume":"50","author":"Muenzer","year":"2011","journal-title":"Rheumatology"},{"issue":"9","key":"10.1016\/j.ymgme.2018.01.003_bb0755","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1203\/00006450-197309000-00004","article-title":"Mucolipidosis III (pseudo-Hurler polydystrophy): multiple lysosomal enzyme abnormalities in serum and cultured fibroblast cells","volume":"7","author":"Thomas","year":"1973","journal-title":"Pediatr. Res."},{"issue":"10","key":"10.1016\/j.ymgme.2018.01.003_bb0760","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1038\/nm1305","article-title":"Mucolipidosis II is caused by mutations in GNPTA encoding the [alpha]\/[beta] GlcNAc-1-phosphotransferase","volume":"11","author":"Tiede","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymgme.2018.01.003_bb0765","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/B978-0-444-59565-2.00042-3","article-title":"Mucoplysaccharidoses and mucolipidoses","volume":"113","author":"Wraith","year":"2013","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.ymgme.2018.01.003_bb0770","first-page":"92","article-title":"Investigation of newborns with abnormal results in a newborn screening program for four lysosomal storage diseases in Brazil","volume":"12","author":"Bravo","year":"2017","journal-title":"Mol. Gen. Metab. Rep."},{"issue":"1","key":"10.1016\/j.ymgme.2018.01.003_bb0775","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1399-0004.1982.tb02080.x","article-title":"Pseudodeficiency of \u03b1-galactosidase A","volume":"21","author":"Bach","year":"1982","journal-title":"Clin. Genet."},{"issue":"2","key":"10.1016\/j.ymgme.2018.01.003_bb0780","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1016\/j.ymgme.2015.12.317","article-title":"Pseudodeficiency of alpha-iduronidase is a common finding identified from newborn screening in the state of Illinois","volume":"117","author":"Keating","year":"2016","journal-title":"Mol. Genet. Metab."},{"issue":"4","key":"10.1016\/j.ymgme.2018.01.003_bb0785","first-page":"798","article-title":"A pseudodeficiency allele (D152N) of the human beta-glucuronidase gene","volume":"57","author":"Vervoort","year":"1995","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2018.01.003_bb0790","author":"HGMD"},{"key":"10.1016\/j.ymgme.2018.01.003_bb0800","first-page":"1","article-title":"Development of a novel 24-plex newborn screening assay","volume":"5","author":"Gelb et al.","year":"2017","journal-title":"J. Inborn Errors Metab. Screen."},{"issue":"11","key":"10.1016\/j.ymgme.2018.01.003_bb0805","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1373\/clinchem.2015.242560","article-title":"Tandem mass spectrometry has a larger analytical range than fluorescence assays of lysosomal enzymes: application to newborn screening and diagnosis of mucopolysaccharidoses types II, IVA, and VI","volume":"61","author":"Kumar","year":"2015","journal-title":"Clin. Chem."},{"issue":"5","key":"10.1016\/j.ymgme.2018.01.003_bb0810","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1373\/clinchem.2004.047167","article-title":"Tandem mass spectrometric analysis of dried blood spots for screening of mucopolysaccharidosis I in newborns","volume":"51","author":"Wang","year":"2005","journal-title":"Clin. Chem."},{"issue":"2","key":"10.1016\/j.ymgme.2018.01.003_bb0815","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/pd.1970100204","article-title":"Prenatal diagnosis of Morquio disease type a using a simple fluorometric enzyme assay","volume":"10","author":"Zhao","year":"1990","journal-title":"Prenat. Diagn."},{"issue":"1","key":"10.1016\/j.ymgme.2018.01.003_bb0825","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/ng.499","article-title":"Exome sequencing identifies the cause of a mendelian disorder","volume":"42","author":"Ng","year":"2010","journal-title":"Nat. Genet."},{"issue":"16","key":"10.1016\/j.ymgme.2018.01.003_bb0830","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1056\/NEJMoa1306555","article-title":"Clinical whole-exome sequencing for the diagnosis of mf,oendelian disorders","volume":"369","author":"Yang","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"18","key":"10.1016\/j.ymgme.2018.01.003_bb0835","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1001\/jama.2014.14601","article-title":"Molecular findings among patients referred for clinical whole-exome sequencing","volume":"312","author":"Yang","year":"2014","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ymgme.2018.01.003_bb0840","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/ejhg.2011.126","article-title":"A mild form of Mucopolysaccharidosis IIIB diagnosed with targeted next-generation sequencing of linked genomic regions","volume":"20","author":"Selmer","year":"2012","journal-title":"Eur. J. Hum. Genet."},{"issue":"4","key":"10.1016\/j.ymgme.2018.01.003_bb0845","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s13311-014-0288-8","article-title":"Next generation sequencing and the future of genetic diagnosis","volume":"11","author":"Lohmann","year":"2014","journal-title":"Neurotheraoeutic."},{"issue":"1","key":"10.1016\/j.ymgme.2018.01.003_bb0850","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1586\/14737159.2016.1121101","article-title":"Current molecular genetics strategies for the diagnosis of lysosomal storage disorders","volume":"16","author":"Giugliani","year":"2016","journal-title":"Expert. Rev. Mol. Diagn."},{"issue":"1","key":"10.1016\/j.ymgme.2018.01.003_bb0855","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13023-017-0583-7","article-title":"Early disease progression of hurler syndrome","volume":"12","author":"Kiely","year":"2017","journal-title":"Orphanet journal of rare diseases"},{"issue":"1","key":"10.1016\/j.ymgme.2018.01.003_bb0860","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10545-016-9981-6","article-title":"Newborn screening for mucopolysaccharidoses: a pilot study of measurement of glycosaminoglycans by tandem mass spectrometry","volume":"40","author":"Kubaski","year":"2017","journal-title":"J. Inherit. Metab. Dis."},{"issue":"1","key":"10.1016\/j.ymgme.2018.01.003_bb0865","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/1750-1172-8-147","article-title":"A pilot newborn screening program for Mucopolysaccharidosis type I in Taiwan","volume":"8","author":"Lin","year":"2013","journal-title":"Orphan. J. Rare Dis."},{"issue":"1","key":"10.1016\/j.ymgme.2018.01.003_bb0870","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jpeds.2014.09.023","article-title":"Lysosomal storage disorder screening implementation: findings from the first six months of full population pilot testing in Missouri","volume":"166","author":"Hopkins","year":"2015","journal-title":"J. Pediatr."},{"issue":"2","key":"10.1016\/j.ymgme.2018.01.003_bb0875","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.jpeds.2013.01.031","article-title":"Identification of infants at risk for developing Fabry, Pompe, or mucopolysaccharidosis-I from newborn blood spots by tandem mass spectrometry","volume":"163","author":"Scott","year":"2013","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2018.01.003_bb0880","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.cca.2014.01.030","article-title":"Detecting multiple lysosomal storage diseases by tandem mass spectrometry\u2014a national newborn screening program in Taiwan","volume":"431","author":"Liao","year":"2014","journal-title":"Clin. Chim. Acta"}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719218300064?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719218300064?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,26]],"date-time":"2020-10-26T11:18:53Z","timestamp":1603711133000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719218300064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":167,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S1096719218300064"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2018.01.003","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical presentation and diagnosis of mucopolysaccharidoses","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2018.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}